EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention (Q45022516)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

8 December 2017

0 references

reperfusion injury

1 reference

based on heuristic

inferred from title

4

object named as

Christoph Bode

1 reference

Europe PubMed Central

8 December 2017

Michał Tendera

5

object named as

Michal Tendera

1 reference

Europe PubMed Central

8 December 2017

Robert A Kloner

3

object named as

Robert A Kloner

1 reference

Europe PubMed Central

8 December 2017

object named as

Bela Merkely

7

0 references

Robert P Giugliano

object named as

Robert P Giugliano

2

0 references

Jacek Godlewski

8

object named as

Jacek Godlewski

1 reference

Europe PubMed Central

8 December 2017

W. Douglas Weaver

15

object named as

W Douglas Weaver

1 reference

Europe PubMed Central

8 December 2017

author name string

C Michael Gibson

1

1 reference

Europe PubMed Central

8 December 2017

András Jánosi

6

1 reference

Europe PubMed Central

8 December 2017

Rim Halaby

9

1 reference

Europe PubMed Central

8 December 2017

Serge Korjian

10

1 reference

Europe PubMed Central

8 December 2017

Yazan Daaboul

11

1 reference

Europe PubMed Central

8 December 2017

Anjan K Chakrabarti

12

1 reference

Europe PubMed Central

8 December 2017

Kathryn Spielman

13

1 reference

Europe PubMed Central

8 December 2017

Brandon J Neal

14

1 reference

Europe PubMed Central

8 December 2017

publication date

19 November 2015

1 reference

Europe PubMed Central

8 December 2017

European Heart Journal

1 reference

Europe PubMed Central

8 December 2017

37

1 reference

Europe PubMed Central

8 December 2017

16

1 reference

Europe PubMed Central

8 December 2017

1296-1303

1 reference

Europe PubMed Central

8 December 2017

Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Myocardial reperfusion: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Bendavia, a mitochondria-targeting peptide, improves postinfarction cardiac function, prevents adverse left ventricular remodeling, and restores mitochondria-related gene expression in rats

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thromb

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNI

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV597

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHV597

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45022516&oldid=2094596443"